[1]
R. Bedlack, D. Heitzman, and J. Shefner, “A Worsening Problem in ALS: Insurance Barriers Between Drug Approvals and Patient Access”, rrnmf, vol. 5, no. 1, Mar. 2024, doi: 10.17161/rrnmf.v5i1.21232.